Health Care

Commentary

Here’s what “radical transparency” on health care can look like

“Radical transparency” has become a favorite phrase of the Trump administration. The president recently signed an executive order that aims to “empower patients with clear, accurate, and actionable pricing information.” If hospitals and insurers comply — and that’s a big if — patients will finally be able to shop for ...
Commentary

Congress Ought To Dismantle The Healthcare Deep State

One senior Department of Government Efficiency (DOGE) staffer is reportedly trying to shield the Center for Medicare and Medicaid Innovation (CMMI) from mass layoffs and budget cuts, according to a recent Politico expose. That’s a shame. If there’s any agency in Washington that deserves to be cut to the bone—or ...
Commentary

The Private Sector Is Setting The PACE For Managed Care

Rising demand for long-term care is inevitable as more and more baby boomers retire. Meeting this demand will be a challenge. Recent evidence from the PACE program demonstrates that for-profit care providers can help meet this growing demand, but only if the regulatory environment allows it. Read the op-ed here.
Commentary

Medicaid reform is popular

Congressional Republicans keep dodging questions about cuts to Medicaid, the federal-state entitlement that covers nearly 80 million people. But they should not be shy about their plans to reform the entitlement. New polling shows that many of the GOP’s ideas for Medicaid aren’t just smart policy. They’re popular. A survey ...
Commentary

Price Controls Won’t End Global Pharma Freeloading

A new paper by the America First Policy Institute, a think tank with close ties to the Trump administration, has revived the debate over global drug pricing. The paper points out that patients in the United States tend to pay considerably more for brand-name prescription drugs than those in most ...
Commentary

Here’s How Trump’s Pick To Lead The FDA Can Supercharge The Agency

The U.S. Senate last week confirmed former Johns Hopkins surgeon and professor Dr. Marty Makary to lead the Food and Drug Administration. During his confirmation hearing, Makary said his goals for the agency were “more cures and meaningful treatments for Americans.” Throughout the hearing, he offered insight on how he ...
Blog

Counting the Cost of Single-Payer

Sen. Bernie Sanders, I-Vt., is back on the road promoting Medicare for All. “We are the only major nation on earth that does not guarantee health care to all people as a human right,” he complained in a recent speech in Nevada. But the Vermont senator failed to explain how ...
Commentary

Democrats in Calif. Put Healthcare of Illegal Residents First

Free healthcare doesn’t come cheap. That’s one lesson Gov. Gavin Newsom, D-Calif., is learning the hard way. Since Newsom officially extended the state’s Medicaid program, Medi-Cal, to all undocumented immigrants last year, the entitlement’s costs have ballooned. Read the op-ed here.
Commentary

Big savings can be found in improper Medicare spending

Republicans are searching for ways to eliminate “fraud, waste, and abuse” in Medicaid, the federal-state entitlement created to provide health coverage for low-income, pregnant, homeless, and disabled people. It’s long past time. According to a new report from the Paragon Health Institute’s Brian Blase and the Economic Policy Innovation Center’s ...
Blog

Imposing Price Controls on U.S. Drugs Won’t Level the Playing Field

The cost of capital for developing a new drug is $2.9 billion, including post approval research and development costs. Meanwhile, the process to develop a drug takes 10 years and only 12 percent of drugs make it to market. These costs do not change simply because governments impose price controls ...
Commentary

Here’s what “radical transparency” on health care can look like

“Radical transparency” has become a favorite phrase of the Trump administration. The president recently signed an executive order that aims to “empower patients with clear, accurate, and actionable pricing information.” If hospitals and insurers comply — and that’s a big if — patients will finally be able to shop for ...
Commentary

Congress Ought To Dismantle The Healthcare Deep State

One senior Department of Government Efficiency (DOGE) staffer is reportedly trying to shield the Center for Medicare and Medicaid Innovation (CMMI) from mass layoffs and budget cuts, according to a recent Politico expose. That’s a shame. If there’s any agency in Washington that deserves to be cut to the bone—or ...
Commentary

The Private Sector Is Setting The PACE For Managed Care

Rising demand for long-term care is inevitable as more and more baby boomers retire. Meeting this demand will be a challenge. Recent evidence from the PACE program demonstrates that for-profit care providers can help meet this growing demand, but only if the regulatory environment allows it. Read the op-ed here.
Commentary

Medicaid reform is popular

Congressional Republicans keep dodging questions about cuts to Medicaid, the federal-state entitlement that covers nearly 80 million people. But they should not be shy about their plans to reform the entitlement. New polling shows that many of the GOP’s ideas for Medicaid aren’t just smart policy. They’re popular. A survey ...
Commentary

Price Controls Won’t End Global Pharma Freeloading

A new paper by the America First Policy Institute, a think tank with close ties to the Trump administration, has revived the debate over global drug pricing. The paper points out that patients in the United States tend to pay considerably more for brand-name prescription drugs than those in most ...
Commentary

Here’s How Trump’s Pick To Lead The FDA Can Supercharge The Agency

The U.S. Senate last week confirmed former Johns Hopkins surgeon and professor Dr. Marty Makary to lead the Food and Drug Administration. During his confirmation hearing, Makary said his goals for the agency were “more cures and meaningful treatments for Americans.” Throughout the hearing, he offered insight on how he ...
Blog

Counting the Cost of Single-Payer

Sen. Bernie Sanders, I-Vt., is back on the road promoting Medicare for All. “We are the only major nation on earth that does not guarantee health care to all people as a human right,” he complained in a recent speech in Nevada. But the Vermont senator failed to explain how ...
Commentary

Democrats in Calif. Put Healthcare of Illegal Residents First

Free healthcare doesn’t come cheap. That’s one lesson Gov. Gavin Newsom, D-Calif., is learning the hard way. Since Newsom officially extended the state’s Medicaid program, Medi-Cal, to all undocumented immigrants last year, the entitlement’s costs have ballooned. Read the op-ed here.
Commentary

Big savings can be found in improper Medicare spending

Republicans are searching for ways to eliminate “fraud, waste, and abuse” in Medicaid, the federal-state entitlement created to provide health coverage for low-income, pregnant, homeless, and disabled people. It’s long past time. According to a new report from the Paragon Health Institute’s Brian Blase and the Economic Policy Innovation Center’s ...
Blog

Imposing Price Controls on U.S. Drugs Won’t Level the Playing Field

The cost of capital for developing a new drug is $2.9 billion, including post approval research and development costs. Meanwhile, the process to develop a drug takes 10 years and only 12 percent of drugs make it to market. These costs do not change simply because governments impose price controls ...
Scroll to Top